Clinical Trial Update: Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating lymphocyte-sparing radio-immunotherapy for head and neck cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Oropharynx Cancer, Larynx Cancer | Phase 3 | Status: RECRUITING